NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The Canadian leader’s message comes after several U.S. partners in Europe showed support for Trump’s trilateral proposal on Friday.Read More